Open Label Extension Study of AMX0035 in Patients With ALS

NCT03488524 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis
ALS

Interventions

DRUG: AMX0035

Sponsor

Amylyx Pharmaceuticals Inc.

Collaborators

[object Object]